Ls Investment Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Ls Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$17.99 - $22.22 $19,932 - $24,619	-1,108 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$17.07 - $20.64 $43,886 - $53,065	-2,571 Reduced 69.88%	1,108 $21,000
Q1 2019 Apr 25, 2019	BUY	$19.46 - $25.28 $3,055 - $3,968	157 Added 4.46%	3,679 $75,000
Q4 2018 Feb 01, 2019	BUY	$17.72 - $22.51 $42,776 - $54,339	2,414 Added 217.87%	3,522 $70,000
Q4 2017 Feb 07, 2018	SELL	$17.76 - $19.75 $6,695 - $7,445	-377 Reduced 25.39%	1,108 $21,000
Q3 2017 Oct 19, 2017	BUY	$14.73 - $17.99 $21,874 - $26,715	1,485	1,485 $27,000

287

35.1M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.23B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.